<DOC>
	<DOCNO>NCT00577447</DOCNO>
	<brief_summary>The purpose study test hypothesis dietary supplementation omega-3 fatty acid docosahexaenoic acid ( DHA ) improve behavior child autism .</brief_summary>
	<brief_title>Docosahexaenoic Acid Treatment Autism</brief_title>
	<detailed_description>Autism neurodevelopmental disability increase prevalence . Traditional medicine offer cure autism ; thus , many parent child autism attract complementary alternative therapy , one dietary supplementation long chain polyunsaturated omega-3 fatty acid , docosahexaenoic acid ( DHA ) . DHA critical structural lipid brain cell membrane difference brain DHA content may influence synaptic function , particularly nutritionally-sensitive area brain , cerebellum hippocampus , may brain structure involve etiology autism . This study randomize , double-blind , placebo-controlled trial investigate whether DHA supplementation effective treatment child autism . Eighty child autism randomize receive 200mg DHA placebo 6 month . Outcome variable include total plasma fatty acid pattern score parent investigator-completed behavioral developmental rating scale baseline 3 6 month supplementation . Differences group 6 month evaluate use regression method . Regression analysis use detect correlation plasma total fatty acid DHA content score various outcome measure . Results study either provide evidence breakthrough biomedical treatment alternative child autism evidenced-based advice desperate parent regard choice potential treatment child autism</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<criteria>Meet DSMIV criterion autistic disorder Age 3 10 year Use dietary supplement contain DHA within 90 day study inclusion Medical history disorder lipid metabolism</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>autism</keyword>
	<keyword>omega-3 fatty acid</keyword>
	<keyword>docosahexaenoic acid</keyword>
</DOC>